Home/Pipeline/TAK-573

TAK-573

Solid tumors

Phase 1Active

Key Facts

Indication

Solid tumors

Phase

Phase 1

Status

Active

Company

Takeda Pharmaceutical

About Takeda Pharmaceutical

Founded in 1781, Takeda is a leading global biopharmaceutical company headquartered in Tokyo, Japan, with operations in over 80 countries. The company transformed through strategic acquisitions including Shire in 2019, building a diversified portfolio in oncology, rare diseases, neuroscience, and gastroenterology. Takeda focuses on developing breakthrough therapies while maintaining a strong commercial presence with blockbuster drugs generating billions in annual revenue.

View full company profile

Therapeutic Areas

Oncology Rare Diseases Neuroscience Gastroenterology

Other Solid tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active
ONO-4538 combinations	Ono Pharmaceutical	Phase 2	Active